CashI can hardly believe I'm writing this... and I'm sure I will regret it... but Cashmachine is right. This stock is where it is today because of management and Stormont. They have been oddly quiet which makes me believe all the past press was for Stormont's sake so that he could dump his shares. The good news, he is hopefully done.
All this being said, the GAP offering is strong and it has been backed up by independent groups. I believe that the merit of this company lies in the hands of Sloan Keetering. In 2006, it was their testing that made GAP change their drug... I think that NCI filled in a few pieces of the puzzle and their guy at Sloan should fill in the rest. I own SSS and there was nothing that should have caused the jump it got last week... and outside of appearances they really don't release anything like GAP has in the past 8 months. Who knows what it will take... but this one will move, but like SSS it will probably be without warning. Investors are waiting for something to validate that they have what they have... a NR from GAP may not be enough.... a leak from Sloan, NCI, or OHRI may do the trick though.